Key facts
- This page summarizes Fu Tao's Form 4 filing for Zai Lab Ltd (ZLAB).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 29 Oct 2021, 17:15.
Fu Tao - 28 Oct 2021 Form 4 Insider Report for Zai Lab Ltd (ZLAB)
- Reporting relationship
- President & COO, Director
- Issuer ticker
- ZLAB
- Reported as of
- 28 Oct 2021
- Net transaction value
- -$1,049,978
- SEC form
- 4
- Accepted by SEC
- 29 Oct 2021, 17:15:13 UTC
- Prior SEC filing
- 14 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Bruce A. Blefeld, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Fu Tao filed Form 4 for Zai Lab Ltd (ZLAB) on 29 Oct 2021.
Change
- Previous filing in this sequence was filed on 14 Oct 2021.
- Current net transaction value: -$1,049,978.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZLAB
transaction
Ordinary Shares
Sale
- Transaction value
- $215,772
- Shares
- -2,065
- Change %
- -2.4%
- Price
- $104.49
- Shares after
- 85,435
- Date
- 28 Oct 2021
- Ownership
- See footnote
- Footnotes
- F1, F2, F4
ZLAB
transaction
Ordinary Shares
Sale
- Transaction value
- $834,207
- Shares
- -7,935
- Change %
- -9.3%
- Price
- $105.13
- Shares after
- 77,500
- Date
- 28 Oct 2021
- Ownership
- See footnote
- Footnotes
- F1, F3, F4
ZLAB
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 187,668
- Date
- 28 Oct 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person's spouse, dated June 17, 2021, expires February 28, 2022 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
Footnote F2
Reflects a weighted average sale price of $104.49 per share, at prices ranging from $103.77 to $104.76 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Footnote F3
Reflects a weighted average sale price of $105.13 per share, at prices ranging from $104.87 to $105.40 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Footnote F4
Shares held by Reporting Person's spouse.